These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2312862)

  • 21. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
    Schmidt GP; Baur-Melnyk A; Haug A; Heinemann V; Bauerfeind I; Reiser MF; Schoenberg SO
    Eur J Radiol; 2008 Jan; 65(1):47-58. PubMed ID: 18082989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glioblastoma multiforme metastastic to the bone: diagnosis by (18)F-NaF PET/CT.
    Derlin T; Clauditz TS; Bannas P
    Clin Nucl Med; 2014 Feb; 39(2):188-9. PubMed ID: 24300358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
    Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
    Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staging non-small cell lung cancer with whole-body PET.
    Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
    Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skeletal metastases: an update of the literature with pictorial review.
    Zampakis P; Romanos O; Kraniotis P; Solomou EK
    J BUON; 2011; 16(1):24-37. PubMed ID: 21674846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-body MR imaging: evaluation of patients for metastases.
    Lauenstein TC; Goehde SC; Herborn CU; Goyen M; Oberhoff C; Debatin JF; Ruehm SG; Barkhausen J
    Radiology; 2004 Oct; 233(1):139-48. PubMed ID: 15317952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
    Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone tumors: magnetic resonance imaging versus computed tomography.
    Zimmer WD; Berquist TH; McLeod RA; Sim FH; Pritchard DJ; Shives TC; Wold LE; May GR
    Radiology; 1985 Jun; 155(3):709-18. PubMed ID: 4001374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging of prostate cancer.
    Akin O; Hricak H
    Radiol Clin North Am; 2007 Jan; 45(1):207-22. PubMed ID: 17157630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant ameloblastoma with thoracic vertebral metastasis: PET/CT and MR imaging.
    Nguyen BD
    Clin Nucl Med; 2005 Jun; 30(6):450-2. PubMed ID: 15891309
    [No Abstract]   [Full Text] [Related]  

  • 31. [The value of imaging techniques for bone metastases].
    Kratochwil C
    Urologe A; 2007 Aug; 46(8):891-6. PubMed ID: 17653687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
    Peters TT; Senft A; Hoekstra OS; Castelijns JA; Witte BI; Leemans CR; de Bree R
    Oral Oncol; 2015 Mar; 51(3):267-71. PubMed ID: 25552384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPIO-enhanced magnetic resonance imaging for the detection of metastases in sentinel nodes localized by computed tomography lymphography in patients with breast cancer.
    Motomura K; Ishitobi M; Komoike Y; Koyama H; Noguchi A; Sumino H; Kumatani Y; Inaji H; Horinouchi T; Nakanishi K
    Ann Surg Oncol; 2011 Nov; 18(12):3422-9. PubMed ID: 21607775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
    Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
    Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
    Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer imaging.
    Kundra V
    Semin Roentgenol; 2006 Apr; 41(2):139-49. PubMed ID: 16697892
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone marrow metastases from glioblastoma multiforme--A case report and review of the literature.
    Rajagopalan V; El Kamar FG; Thayaparan R; Grossbard ML
    J Neurooncol; 2005 Apr; 72(2):157-61. PubMed ID: 15925996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of contrast-enhanced computed tomography for assessment of mandibular and medial retropharyngeal lymph node metastasis in dogs with oral and nasal cancer.
    Skinner OT; Boston SE; Giglio RF; Whitley EM; Colee JC; Porter EG
    Vet Comp Oncol; 2018 Dec; 16(4):562-570. PubMed ID: 29989306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.